Search Results for 'china'
Contract Service Directory Companies
View All Buyers Guide Companies »
-
Excipients
Bye-Bye China?
Instead of closing its doors on China, Western pharma industry needs to take a balanced approach and perform proper due diligence based on objective criteria.Michele Jermini and Enrico Polastro 11.17.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Samsung Biologics Expands in China
Partners with Chinese biotech GeneQuantum Healthcare on ADC development.Contract Pharma Staff 11.03.20
-
APIs
Are the Challenges of Chinese API Manufacturing Sparking a Shift Back to the US?
Five challenges that face U.S. and Chinese API manufacturing relations.Ed Price, President, Seqens North America 06.19.20
-
Bio News | Breaking News | CRO News | Drug Development | Industry News
PPD Expanding Capabilities in China
Enhancing drug development for international pharma companies and Chinese biotechs.01.09.20
-
Breaking News | Drug Development | Industry News
Amgen’s Expansion Plans in China Underway
The companies will collaborate to advance 20 medicines from Amgen's innovative oncology pipeline in China01.02.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Avantor Boosts Biopharmaceutical Innovation in China
Opens innovation and customer support center in Shanghai.12.11.19
-
iBio, CC-Pharming Expand Collaboration in China
Licenses to iBio’s Bio-Better Rituximab and FastPharming™ System expand commercial partnership08.27.19
-
Biologics, Proteins, Vaccines
Outsourcing in China: How far can it go?
China’s biopharmaceutical services market is on pace to top $1 billion by 2021Vicky Qing Xia, BioPlan Associates 07.15.19
-
Biologics, Proteins, Vaccines | Biosimilars
Contract BioManufacturing in China: Creating a New Segment
An up-close look at China’s growing market for CMO services.Vicky Qing Xia and Leo Cai Yang, BioPlan Associates 04.10.18
-
APIs | Capsules | Clinical Trials | Drug Development | Drug Discovery | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Injectables | Inspections | Logistics | Lyophilization | Methods Development | Process Development | QA/QC | Regulatory Affairs | Scale-up/Technology Transfer | Serialization | Supply Chain | Validation
CMOs and Final Dosage Manufacturing in China
The far east market evolvesOliver Mueller and Clifford Mintz, Suzhou Pharma Services and BioInsights 05.30.12
